Clinical trial
Study on the Effects of an AMP Challenge on Asthmatic Patients Following…
NCT00400855 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00400855 |
|---|---|
| Title | Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone Propionate |
| Official title | A Randomised, Double-blind, Placebo-controlled, Incomplete Block, 4-period Crossover, Study to Investigate the Effects of 5-day Repeat Inhaled Doses of Fluticasone Propionate (BID, 50-2000 mcg) on Airway Responsiveness to Adenosine 5-monophosphate (AMP) Challenge When Delivered After the Last Dose… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Fluticasone propionate |
| Enrollment | 49 |
| Start date | Jan 1, 2005 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Nov 17, 2006 |
| Last update posted | Sep 15, 2016 |
| Countries | New Zealand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: